{"id":62754,"date":"2025-10-23T16:43:11","date_gmt":"2025-10-23T16:43:11","guid":{"rendered":"https:\/\/www.europesays.com\/se\/62754\/"},"modified":"2025-10-23T16:43:11","modified_gmt":"2025-10-23T16:43:11","slug":"dicot-pharma-rapporterar-okad-rorelseforlust-i-q3","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/se\/62754\/","title":{"rendered":"Dicot Pharma rapporterar \u00f6kad r\u00f6relsef\u00f6rlust i Q3"},"content":{"rendered":"<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Forskningsbolaget Dicot Pharma redovisar som planerat ingen oms\u00e4ttning under tredje kvartalet. R\u00f6relsef\u00f6rlusten \u00f6kade.<\/p>\n<p>R\u00f6relseresultatet blev -16,6 miljoner kronor (-10,4). <\/p>\n<p>Resultatet efter skatt blev -16,1 miljoner kronor (-10,2). <\/p>\n<p>Resultat per aktie uppgick till -0,01 kronor (-0,01). <\/p>\n<p>Likvida medel uppgick till 90,0 miljoner kronor (130,4).<\/p>\n<p>Dicot sl\u00e4ppte under morgonen resultat f\u00f6r fas 2a-studie med l\u00e4kemedelskandidaten LIB-01. Bolaget sade sig vara n\u00f6jda med resultaten, men dess aktie fick en dramatisk dag p\u00e5 b\u00f6rsen med ett stort kursfall. Som mest var kursen ned \u00f6ver 60 procent. <\/p>\n<p>&#8221;Resultaten visar att LIB-01 har effekt p\u00e5 erektionsf\u00f6rm\u00e5gan och att den \u00e4r l\u00e5ngtidsverkande p\u00e5 ett s\u00e4tt som \u00e4r helt unikt i sitt slag. Utfallet p\u00e5visar LIB01s potential att bli en innovation som kan rita om spelplanen f\u00f6r erektionsbehandlingar. Som bolag \u00e4r vi nu p\u00e5 n\u00e4sta niv\u00e5, med resultat som kvalificerar oss f\u00f6r att g\u00e5 vidare i den kliniska utvecklingen&#8221;, s\u00e4ger vd Elin Trampe i samband med rapportsl\u00e4ppet. <br class=\"col-start-2\"\/><\/p>\n<tr class=\"odd:bg-surf-grey dark:odd:bg-surf-grey-dark even:bg-surf-main dark:even:bg-surf-main-dark\">\n<td class=\"p-2 text-start min-h-10 relative max-w-[250px] border-r border-b border-border dark:border-border-dark last:border-r-0 break-words\">\n<p>Dicot Pharma, Mkr<\/p>\n<\/td>\n<td class=\"p-2 text-start min-h-10 relative max-w-[250px] border-r border-b border-border dark:border-border-dark last:border-r-0 break-words\">\n<p>Q3-2025<\/p>\n<\/td>\n<td class=\"p-2 text-start min-h-10 relative max-w-[250px] border-r border-b border-border dark:border-border-dark last:border-r-0 break-words\">\n<p>Q3-2024<\/p>\n<\/td>\n<td class=\"p-2 text-start min-h-10 relative max-w-[250px] border-r border-b border-border dark:border-border-dark last:border-r-0 break-words\">\n<p>F\u00f6r\u00e4ndring<\/p>\n<\/td>\n<\/tr>\n<tr class=\"odd:bg-surf-grey dark:odd:bg-surf-grey-dark even:bg-surf-main dark:even:bg-surf-main-dark\">\n<td class=\"p-2 text-start min-h-10 relative max-w-[250px] border-r border-b border-border dark:border-border-dark last:border-r-0 break-words\">\n<p>R\u00f6relseresultat<\/p>\n<\/td>\n<td class=\"p-2 text-start min-h-10 relative max-w-[250px] border-r border-b border-border dark:border-border-dark last:border-r-0 break-words\">\n<p>-16,6<\/p>\n<\/td>\n<td class=\"p-2 text-start min-h-10 relative max-w-[250px] border-r border-b border-border dark:border-border-dark last:border-r-0 break-words\">\n<p>-10,4<\/p>\n<\/td>\n<td class=\"p-2 text-start min-h-10 relative max-w-[250px] border-r border-b border-border dark:border-border-dark last:border-r-0 break-words\"\/><\/tr>\n<tr class=\"odd:bg-surf-grey dark:odd:bg-surf-grey-dark even:bg-surf-main dark:even:bg-surf-main-dark\">\n<td class=\"p-2 text-start min-h-10 relative max-w-[250px] border-r border-b border-border dark:border-border-dark last:border-r-0 break-words\">\n<p>Nettoresultat<\/p>\n<\/td>\n<td class=\"p-2 text-start min-h-10 relative max-w-[250px] border-r border-b border-border dark:border-border-dark last:border-r-0 break-words\">\n<p>-16,1<\/p>\n<\/td>\n<td class=\"p-2 text-start min-h-10 relative max-w-[250px] border-r border-b border-border dark:border-border-dark last:border-r-0 break-words\">\n<p>-10,2<\/p>\n<\/td>\n<td class=\"p-2 text-start min-h-10 relative max-w-[250px] border-r border-b border-border dark:border-border-dark last:border-r-0 break-words\"\/><\/tr>\n<tr class=\"odd:bg-surf-grey dark:odd:bg-surf-grey-dark even:bg-surf-main dark:even:bg-surf-main-dark\">\n<td class=\"p-2 text-start min-h-10 relative max-w-[250px] border-r border-b border-border dark:border-border-dark last:border-r-0 break-words\">\n<p>Resultat per aktie, kronor<\/p>\n<\/td>\n<td class=\"p-2 text-start min-h-10 relative max-w-[250px] border-r border-b border-border dark:border-border-dark last:border-r-0 break-words\">\n<p>-0,01<\/p>\n<\/td>\n<td class=\"p-2 text-start min-h-10 relative max-w-[250px] border-r border-b border-border dark:border-border-dark last:border-r-0 break-words\">\n<p>-0,01<\/p>\n<\/td>\n<td class=\"p-2 text-start min-h-10 relative max-w-[250px] border-r border-b border-border dark:border-border-dark last:border-r-0 break-words\"\/><\/tr>\n<tr class=\"odd:bg-surf-grey dark:odd:bg-surf-grey-dark even:bg-surf-main dark:even:bg-surf-main-dark\">\n<td class=\"p-2 text-start min-h-10 relative max-w-[250px] border-r border-b border-border dark:border-border-dark last:border-r-0 break-words\">\n<p>Likvida medel<\/p>\n<\/td>\n<td class=\"p-2 text-start min-h-10 relative max-w-[250px] border-r border-b border-border dark:border-border-dark last:border-r-0 break-words\">\n<p>90,0<\/p>\n<\/td>\n<td class=\"p-2 text-start min-h-10 relative max-w-[250px] border-r border-b border-border dark:border-border-dark last:border-r-0 break-words\">\n<p>130,4<\/p>\n<\/td>\n<td class=\"p-2 text-start min-h-10 relative max-w-[250px] border-r border-b border-border dark:border-border-dark last:border-r-0 break-words\">\n<p>-31,0%<\/p>\n<\/td>\n<\/tr>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Joel Andersson<br class=\"col-start-2\"\/>Nyhetsbyr\u00e5n Finwire<\/p>\n","protected":false},"excerpt":{"rendered":"Forskningsbolaget Dicot Pharma redovisar som planerat ingen oms\u00e4ttning under tredje kvartalet. R\u00f6relsef\u00f6rlusten \u00f6kade. R\u00f6relseresultatet blev -16,6 miljoner kronor&hellip;\n","protected":false},"author":2,"featured_media":261,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[22,23,26,27,17,21,24,25,28,29,15,16,18,34,31,33,32,30,19,20],"class_list":{"0":"post-62754","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-rubriker","8":"tag-breaking-news","9":"tag-breakingnews","10":"tag-featured-news","11":"tag-featurednews","12":"tag-headlines","13":"tag-huvudnyheter","14":"tag-latest-news","15":"tag-latestnews","16":"tag-main-news","17":"tag-mainnews","18":"tag-news","19":"tag-nyheter","20":"tag-rubriker","21":"tag-se","22":"tag-svenska","23":"tag-sverige","24":"tag-sweden","25":"tag-swedish","26":"tag-top-stories","27":"tag-topstories"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@se\/115424487219549026","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/62754","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/comments?post=62754"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/62754\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media\/261"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media?parent=62754"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/categories?post=62754"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/tags?post=62754"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}